{"id":24100,"date":"2022-08-16T07:34:57","date_gmt":"2022-08-16T07:34:57","guid":{"rendered":"https:\/\/zeepedia.com\/?p=24100"},"modified":"2022-08-17T08:11:05","modified_gmt":"2022-08-17T08:11:05","slug":"synagogue","status":"publish","type":"post","link":"https:\/\/zeepedia.com\/medical\/medicines\/synagogue\/","title":{"rendered":"Synagogue &#8211; Palivizumab uses, dose and side effects"},"content":{"rendered":"\n<p>50 mg\/0.5 ml and 100 mg\/1 ml&nbsp;solution&nbsp;<\/p>\n\n\n\n<p>for injection<br>Active substance: palivizumab<a><\/a><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">What Synagis is and what it is used for<\/h2>\n\n\n\n<p>Synagis contains the active substance palivizumab, which is an\u00a0antibody.\u00a0It works specifically against a\u00a0virus\u00a0called a respiratory syncytial\u00a0virus,\u00a0RSV.<\/p>\n\n\n\n<p>Your child is at high risk of contracting an illness caused by a&nbsp;virus&nbsp;called respiratory syncytial&nbsp;virus&nbsp;(&nbsp;RSV&nbsp;).<\/p>\n\n\n\n<p>Children who are more susceptible to severe&nbsp;RSV&nbsp;disease (high-risk children) include premature children (born at 35 weeks or earlier) or children with certain heart or lung problems.<\/p>\n\n\n\n<p>Synagis is a medicine that helps prevent your child from getting severe&nbsp;RSV&nbsp;disease.<br><a><\/a><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">What you need to know before Synagis is given to your child<\/h2>\n\n\n\n<h2 class=\"wp-block-heading\">Your child should not use Synagis<\/h2>\n\n\n\n<p>If the child is allergic to palivizumab or any of the other ingredients (listed in section 6).&nbsp;Signs and symptoms of a severe&nbsp;allergic reaction&nbsp;may include:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>severe skin rash,\u00a0hives,\u00a0or itchy skin<\/li><li>swelling of the lips, tongue, or face<\/li><li>closing of the throat, difficulty swallowing<\/li><li>difficulty breathing, rapid or irregular breathing<\/li><li>bluish color on skin, lips, or under fingernails<\/li><li>muscle weakness or weakness<\/li><li>blood pressure drop<\/li><li>inadmissibility<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Warnings and precautions<\/h2>\n\n\n\n<p>Take special care with Synagis<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>if your child is unwell.\u00a0Tell the doctor, as treatment with Synagis, may need to be postponed.<\/li><li>Synagis is usually injected into the thigh.\u00a0Remember to tell the doctor if your child has any kind of bleeding disorder.<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Other medicines and Synagis<\/h2>\n\n\n\n<p>It has not been shown that Synagis affects or is affected by other medicines.&nbsp;However, if your child is receiving other medicines, you should inform the doctor about this before starting treatment with Synagis.<a><\/a><a><\/a><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">How will your child receive Synagis?<\/h2>\n\n\n\n<p><em>How often will my child receive Synagis?<\/em><\/p>\n\n\n\n<p>Synagis should be given to your child once a month at a&nbsp;dose&nbsp;of 15 mg per kg of body weight as long as there is a risk of an&nbsp;RSV&nbsp;infection.&nbsp;To get the best protection for your child, it is necessary to follow the instructions given by your doctor regarding return visits for refill doses of Synagis.<\/p>\n\n\n\n<p>If your child is to undergo heart surgery (&nbsp;bypass&nbsp;surgery), an additional&nbsp;dose of&nbsp;Synagis may be given after the surgery.&nbsp;Your child can then go back to the injection schedule that was originally planned.<\/p>\n\n\n\n<p><em>How will Synagis be given to my child?<\/em><\/p>\n\n\n\n<p>Synagis will be given by&nbsp;injection&nbsp;into a muscle, usually on the outside of the thigh.<\/p>\n\n\n\n<p><em>What should I do if the child misses an&nbsp;injection&nbsp;of Synagis?<\/em><\/p>\n\n\n\n<p>If the child misses an\u00a0injection, you should contact your doctor as soon as possible.\u00a0Each Synagis\u00a0injection\u00a0is effective for about one month, after which the next\u00a0injection\u00a0must be given.<\/p>\n\n\n\n<p>Always use this medicine as directed by your doctor or pharmacist.&nbsp;If you are not sure how this medicine will be given to your child, ask your doctor or pharmacist.<a><\/a><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Possible side effects<\/h2>\n\n\n\n<p>Like all medicines, this medicine can cause\u00a0side effects, although not everybody gets them.<\/p>\n\n\n\n<p><em>Synagis can cause serious&nbsp;side effects&nbsp;that include:<\/em><\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>severe allergic reactions, these reactions can be life-threatening or fatal (see \u201cYour child should not use Synagis\u201d for a list of signs and symptoms).<\/li><li>unusual bruising or groups of small red dots on the skin<\/li><\/ul>\n\n\n\n<p>Contact your doctor or seek medical attention immediately if your child experiences any of the serious&nbsp;side effects&nbsp;listed above after receiving a&nbsp;dose&nbsp;of Synagis.<\/p>\n\n\n\n<p><strong>Additional\u00a0side effects\u00a0ar<\/strong><\/p>\n\n\n\n<p>Very common (occurs in at least 1 in 10 users)<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>rash<\/li><li>fever<\/li><\/ul>\n\n\n\n<p>Common (affects 1 to 10 users in 100)<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>pain,\u00a0redness,\u00a0or swelling at the injection site<\/li><li>pauses in breathing or other breathing problems<\/li><\/ul>\n\n\n\n<p>Uncommon (affects less than 1 in 100 users)<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>convulsions<\/li><li>hives<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">How to store Synagis<\/h2>\n\n\n\n<p>Store out of sight and reach of children.<\/p>\n\n\n\n<p>Use before the expiry date stated on the carton and label after &#8220;EXP&#8221;.&nbsp;The expiration date is the last day of the specified month.<\/p>\n\n\n\n<p>Store in a refrigerator (2 \u00b0C-8 \u00b0C).<\/p>\n\n\n\n<p>Do not freeze.<\/p>\n\n\n\n<p>Store the vial in the outer carton.&nbsp;Light sensitive.<a><\/a><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Contents of the packaging and other information<\/h2>\n\n\n\n<h2 class=\"wp-block-heading\">Contents declaration<\/h2>\n\n\n\n<ul class=\"wp-block-list\"><li>The active substance is palivizumab.\u00a0One ml of Synagis\u00a0solution for injection\u00a0contains 100 mg of palivizumab.<\/li><li>Each 0.5 ml\u00a0vial\u00a0contains 50 mg palivizumab<\/li><li>Each 1 ml\u00a0vial\u00a0contains 100 mg palivizumab<\/li><li>Other ingredients are histidine,\u00a0glycine,\u00a0and water for vials.<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">What Synagis looks like and pack sizes<\/h2>\n\n\n\n<p>Synagis\u00a0solution for injection\u00a0is a clear or slightly opalescent solution available in 0.5 ml or 1 ml vials.<\/p>\n\n\n\n<p>One&nbsp;vial&nbsp;per pack.<a><\/a><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Marketing Authorisation Holder<\/h2>\n\n\n\n<p><strong>Manufacturer<\/strong><\/p>\n\n\n\n<p>AbbVie Srl<\/p>\n\n\n\n<p>04011 Campoverde di Aprilia (LT)<\/p>\n\n\n\n<p>Italy<\/p>\n\n\n\n<p>For further information about this medicine, contact the representative of the marketing authorization holder.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table><tbody><tr><td><strong>Belgi\u00eb\/Belgique\/Belgien<br><\/strong>AstraZeneca SA\/NV<br>Tel: +32 2 370 48 11<\/td><td><strong>Lietuva<br><\/strong>UAB AstraZeneca Lietuva<br>Tel: +370 5 2660550<\/td><\/tr><tr><td><strong><br><\/strong>Bulgaria AstraZeneca Bulgaria EOOD&nbsp;<strong>Tel<\/strong><br>.: +359 2 44 55 000<\/td><td><strong>Luxembourg\/Luxembourg<br><\/strong>AstraZeneca SA\/NVT\u00e9l\/Tel: +32 2 370 48 11<\/td><\/tr><tr><td><strong>Czech Republic<\/strong>AstraZeneca Czech Republic s.r.o.<br>Tel: +420 222 807 111<\/td><td><strong>Magyarorsz\u00e1g<\/strong>AstraZeneca Kft.Tel.: +36 1 883 6500<\/td><\/tr><tr><td><strong>Denmark<\/strong>AstraZeneca A\/SPhone: +45 43 66 64 62<\/td><td><strong>Malta<\/strong>Associated Drug Co.&nbsp;LtdPhone: +356 2277 8000<\/td><\/tr><tr><td><strong>Deutschland<\/strong>AstraZeneca GmbHPhone: +49 40 809034100<\/td><td><strong>The Netherlands<\/strong>AstraZeneca BVPhone: +31 79 363 2222<\/td><\/tr><tr><td><strong>Estonia<\/strong>AstraZenecaPhone: +372 6549 600<\/td><td><strong>Norway<\/strong>AstraZeneca iPhone: +47 21 00 64 00<\/td><\/tr><tr><td><strong>Greece<\/strong>AstraZeneca iPhone: +30 2 106871500<\/td><td><strong>Austria<\/strong>AstraZeneca \u00d6sterreich GmbHPhone: +43 1 711 31 0<\/td><\/tr><tr><td><strong>Spain<\/strong>AstraZeneca Farmac\u00e9utica Spain, SAPhone: +34 91 301 91 00<\/td><td><strong>Polish<\/strong>AstraZeneca Pharma Poland Sp.&nbsp;z o. oTel.: +48 22 245 73 00<\/td><\/tr><tr><td><strong>France<\/strong>AstraZenecaTel: +33 1 41 29 40 00<\/td><td><strong>Portugal<\/strong><br>AstraZeneca Produtos Farmac\u00eauticos, Lda.Phone: +351 21 434 61 00<\/td><\/tr><tr><td><strong>Hrvatska<\/strong>AstraZeneca dooPhone: +385 1 4628 000<\/td><td><strong>Romania<\/strong>AstraZeneca Pharma SRLPhone: +40 21 317 60 41<\/td><\/tr><tr><td><strong>Ireland<\/strong>AstraZeneca Pharmaceuticals (Ireland) DACPhone: +353 1609 7100<\/td><td><strong>Slovenija<\/strong>AstraZeneca UK Limited<br>Tel: +386 1 51 35 600<\/td><\/tr><tr><td><strong>Iceland<\/strong>Vistor hf.Telephone: +354 535 7000<\/td><td><strong>Slovenian Republic<\/strong>AstraZeneca AB, ozone: +421 2 5737 7777<\/td><\/tr><tr><td><strong>Italia<\/strong>AstraZeneca S.p.APhone: +39 02 00704500<\/td><td><strong>Finland\/Finland<\/strong>AstraZeneca OyPhone\/Tel: +358 10 23 010<\/td><\/tr><tr><td><strong>Cyprus<\/strong>\u0391\u03bb\u03ad\u03ba\u03c4\u03c9\u03c1 \u03a6\u03b1\u03c1\u00b5\u03b1\u03ba\u03b5\u03c5\u03c4\u03b9\u03ba\u03ae \u039b\u03c4\u03b4<br>\u03a4\u03b7\u03bb: +357 22490305<\/td><td><strong>Sweden<\/strong>AstraZeneca ABPhone: +46 8 553 26 000<\/td><\/tr><tr><td><strong>Latvia<\/strong>SIA AstraZeneca LatvijaPhone: +371 67377100<\/td><td><strong>United Kingdom (Northern Ireland)<\/strong>AstraZeneca UK LtdPhone: +44 1582 386836<\/td><\/tr><\/tbody><\/table><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Synagis contains the active substance palivizumab, which is an\u00a0antibody\u00a0.\u00a0It works specifically against a\u00a0virus\u00a0called respiratory syncytial\u00a0virus\u00a0,\u00a0RSV\u00a0.<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"cybocfi_hide_featured_image":"","footnotes":""},"categories":[2200,18530],"tags":[25067,25059,25062,25063,25060,25066,25058,25064,25061,25065],"class_list":["post-24100","post","type-post","status-publish","format-standard","hentry","category-medicines","category-s","tag-benefits-of-synagogue","tag-palivizumab","tag-palivizumab-injection","tag-palivizumab-side-effects","tag-synagogue","tag-synagogue-side-effects","tag-what-is-palivizumab","tag-what-is-synagogue","tag-what-palivizumab-is-used-for","tag-what-synagogue-is-used-for"],"_links":{"self":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/24100","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/comments?post=24100"}],"version-history":[{"count":5,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/24100\/revisions"}],"predecessor-version":[{"id":24153,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/24100\/revisions\/24153"}],"wp:attachment":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/media?parent=24100"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/categories?post=24100"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/tags?post=24100"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}